These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy. Dougu N; Joho S; Shan L; Shida T; Matsuki A; Uese K; Hirono K; Ichida F; Tanaka K; Nishino I; Inoue H Circ J; 2009 Feb; 73(2):376-80. PubMed ID: 19057086 [TBL] [Abstract][Full Text] [Related]
4. Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency. Majer F; Vlaskova H; Krol L; Kalina T; Kubanek M; Stolnaya L; Dvorakova L; Elleder M; Sikora J Gene; 2012 May; 498(2):183-95. PubMed ID: 22365987 [TBL] [Abstract][Full Text] [Related]
10. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607 [TBL] [Abstract][Full Text] [Related]
11. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing. Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667 [TBL] [Abstract][Full Text] [Related]
12. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Yang Z; McMahon CJ; Smith LR; Bersola J; Adesina AM; Breinholt JP; Kearney DL; Dreyer WJ; Denfield SW; Price JF; Grenier M; Kertesz NJ; Clunie SK; Fernbach SD; Southern JF; Berger S; Towbin JA; Bowles KR; Bowles NE Circulation; 2005 Sep; 112(11):1612-7. PubMed ID: 16144992 [TBL] [Abstract][Full Text] [Related]
13. Profound left ventricular remodeling associated with LAMP2 cardiomyopathy. Maron BJ; Roberts WC; Ho CY; Kitner C; Haas TS; Wright GB; Moazami N; Feldman DS Am J Cardiol; 2010 Oct; 106(8):1194-6. PubMed ID: 20920663 [TBL] [Abstract][Full Text] [Related]
14. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system. Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191 [TBL] [Abstract][Full Text] [Related]
15. Sudden death associated with danon disease in women. Miani D; Taylor M; Mestroni L; D'Aurizio F; Finato N; Fanin M; Brigido S; Proclemer A Am J Cardiol; 2012 Feb; 109(3):406-11. PubMed ID: 22074992 [TBL] [Abstract][Full Text] [Related]
16. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ; JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245 [TBL] [Abstract][Full Text] [Related]
17. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report. Novelli V; Bisignani A; Pelargonio G; Primiano G; Narducci ML; Palmieri V; Tiziano FD; Zeppilli P; Servidei S; Crea F; Genuardi M BMC Cardiovasc Disord; 2020 Apr; 20(1):156. PubMed ID: 32248794 [TBL] [Abstract][Full Text] [Related]
18. Alcalai R; Arad M; Wakimoto H; Yadin D; Gorham J; Wang L; Burns E; Maron BJ; Roberts WC; Konno T; Conner DA; Perez-Atayde AR; Seidman JG; Seidman CE J Am Heart Assoc; 2021 Sep; 10(17):e018829. PubMed ID: 34459252 [TBL] [Abstract][Full Text] [Related]
19. Arrhythmias and fasciculoventricular pathways in patients with Danon disease: A single center experience. Jhaveri S; Herber J; Zahka K; Boyle GJ; Saarel EV; Aziz PF J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1932-1938. PubMed ID: 31240821 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical characteristics of Danon disease among patients with left ventricular hypertrophy and concomitant electrocardiographic preexcitation. Liu Y; Chen X; Wang F; Liang Y; Deng H; Liao H; Zhang Q; Zhang B; Zhan X; Fang X; Shehata M; Wang X; Xue Y; Wu S Mol Genet Genomic Med; 2019 May; 7(5):e638. PubMed ID: 30929317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]